Differential inactivation of CDKN2 and Rb protein in non - small-cell and small-cell lung cancer cell lines

Journal of the National Cancer Institute

Volumn 87, Issue 10, 1995, Pages 756-761

  Kelley, Michael J ^a   Nakagawa, Kazuhiko ^a   Steinberg, Seth M ^a   Mulshine, James L ^a   Kamb, Alexander ^b   Johnson, Bruce E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Utah   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; GENE; GENE ACTIVITY; GENE DELETION; GENE LOSS; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BLOTTING, SOUTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARRIER PROTEINS; DNA, NEOPLASM; GENE DELETION; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMAN; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; PROTEIN P16; RETINOBLASTOMA PROTEIN; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0029046469     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.10.756     Document Type: Article

References (47)

1. Fountain JW, Karayiorgou M, Emstoff MS, et al: Homozygous deletion within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89:10557-10561, 1992
2. Olopade OI, Buchhagen DL, Malik K, et al: Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res 53(10 Suppl): 2410-2415, 1993
3. Merlo A, Gabrielson E, Askin F, et al: Frequent loss of chromosome 9 in human primary non-small cell lung cancer. Cancer Res 54:640-642, 1994
4. Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types [see comment citations in Medline], Science 264:436-440, 1994
5. Nobori T, Miura K, Wu DJ, et al: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753-756, 1994
6. Motokura T, Arnold A: Cyclins and oncogenesis, Biochim Biophys Acta 1155:63-78, 1993
7. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 [see comment citation in Medline], Nature 366:704-707,1993
8. Ihde DC, Pass HI, Glatstein EJ: Small cell lung cancer. In Cancer: Principles and Practice of Oncology (DeVita VT Jr, Heilman S, Rosenberg SA, eds), Philadelphia: Lippincott, 1993, pp 723-758
9. Ginsberg RJ, Kris MG, Armstrong JG: Nonsmall cell lung cancer. In Cancer: Principles and Practice of Oncology (DeVita VT Jr, Heilman S, Rosenberg SA, eds). Philadelphia: Lippincott, 1993, pp 673-723
10. Shimizu E, Coxon A, Otterson GA, et al: RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 9:2441-2448, 1994
11. Yokota J, Akiyama T, Fung YKT, et al: Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. On" cogene 3:471-475, 1988
12. Hensel CH, Hsieh CL, Gazdar AF, et al: Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 50:3067-3072, 1990
13. Harbour JW, Lai SL, Whang-Peng J, et al: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353-357,1988
14. Horowitz JM, Park SH, Bogenmann E, et al: Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87:2774-2779,1990
15. Rygaard K, Sorenson GD, Pettengill OS, et al: Abnormalities in structure and expression of the retinoblastoma gene in small cell lung cancer cell lines and xenografts in nude mice. Cancer Res 50:5312-5317, 1990
16. Kaye FJ, Kratzke RA, Gerster JL, et al: A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 87:6922-6926, 1990
17. Mori N, Yokota J, Akiyama T, et al: Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene 5:1713-1717, 1990
18. Reissmann PT, Koga H, Takahashi R, et al: Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 8:1913-1919, 1993
19. Xu HJ, Quinlan DC, Davidson AG, et al: Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J Natl Cancer Inst 86:695-699, 1994
20. Richardson GE, Tucker MA, Venzon DJ, et al: Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 119:383-390, 1993
21. Shaw GL, Gazdar AF, Phelps R, et al: Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing. Cancer Res 53:5181-5187, 1993
22. Carney DN, Gazdar AF, Bepler G, et al: Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913-2923, 1985
23. Gazdar AF, Carney DN, Nau MM, et al: Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res 45:2924-2930, 1985
24. Stevenson H, Gazdar AF, Phelps R, et al: Tumor cell lines established in vitro: an independent prognostic factor for survival in non-small-cell lung cancer: Ann Intern" Med 113:764-770,1990
25. Simms E, Gazdar AF, Abrams PG, et al: Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor-supplemented medium. Cancer Res 40:4356-4363, 1980
26. Brower M, Carney DN, Oie HK, et al: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res 46:798-806, 1986
27. Davis LG, Kuehl WM, Battey JF: Basic Methods in Molecular Biology, 2nd ed. Norwalk, Conn: Appleton & Lange, 1994, pp 306-395
28. Greer CE, Peterson SL, Kiviat NB, et al: PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. Am J Clin Pathol 95:117-124, 1991
29. Kelley MJ, Pech M, Seuanez HN, et al: Emergence of the kératinocyte growth factor multigene family during the great ape radiation. Proc Natl Acad Sci USA 89:9287-9291, 1992
30. Mehta CR, Patel NR: A network algorithm for performing Fisher’s exact test in r x c contingency tables. J Am Stat Assoc 78:427-434, 1983
31. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
32. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
33. Lukeis R, Irving L, Garson M, et al: Cytogenetics of non-small cell lung cancer: analysis of consistent non-random abnormalities. Genes Chromosom Cancer 2:116-124, 1990
34. Whang-Peng J, Knutsen T, Gazdar A, et al: Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer. Genes Chromosom Cancer 3:168-188, 1991
35. Cairns P, Mao L, Merlo A, et al: Rates of pl6 (MTSl) mutations in primary tumors with 9p loss [letter] [see comment citation in Medline]. Science 265:415-416, 1994
36. Okamoto A, Demetrick DJ, Spillare EA, et al: Mutations and altered expression of the pl6INK4 in human cancer. Proc Natl Acad Sci USA 91:11045-11049, 1994
37. Mori T, Miura K, Aoki T, et al: Frequent somatic mutation of the MTSI/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54:3396-3397, 1994
38. Yamakawa K, Takahashi T, Horio Y, et al: Frequent homozygous deletions in lung cancer cell lines detected by a DNA marker located at 3p2l.3-p22. Oncogene 8:327-330,1993
39. Daly MC, Xiang RH, Buchhagen D, et al: A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene 8:1721-1729, 1993
40. Branch H, Tory K, Kotler F, et al: Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer. Genes Chromosom Cancer 1:240-246, 1990
41. Takahashi T, Suzuki H, Hida T, et al: The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6:1775-1778, 1991
42. Lehman TA, Bennett WP, Metcalf RA. et al: p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51:4090-4096, 1991
43. Sameshima Y, Matsuno Y, Hirohashi S, et al: Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 7:451-457, 1992
44. Bodner SM, Minna JD, Jensen SM, et al: Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene 7:743-749, 1992
45. Mitsudomi T, Steinberg SM, Nau MM, et al: p53 gene mutations in non-small-cell cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180, 1992
46. Otterson GA, Kratzke RA, Coxon A, et al: Absence of pl6INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378, 1994
47. Li Y, Nichols MA, Shay JW, et al: Transcriptional repression of the D-type cyclin-depend-ent kinase inhibitor pl6 by the retinoblastoma gene product pRb. Cancer Res 54:6078-6082, 1994